Terms: = Sarcomas AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
126 results:
1. Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma.
Zhou Y; Ray PS; Zhu J; Stein F; Rettel M; Sekaran T; Sahadevan S; Perez-Perri JI; Roth EK; Myklebost O; Meza-Zepeda LA; von Deimling A; Fu C; Brosig AN; Boye K; Nathrath M; Blattmann C; Lehner B; Hentze MW; Kulozik AE
Nat Commun; 2024 Apr; 15(1):2810. PubMed ID: 38561347
[TBL] [Abstract] [Full Text] [Related]
2. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
[TBL] [Abstract] [Full Text] [Related]
3. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
Wang Y; Ma X; Xu E; Huang Z; Yang C; Zhu K; Dong Y; Zhang C
Clin Transl Med; 2024 Feb; 14(2):e1586. PubMed ID: 38372422
[TBL] [Abstract] [Full Text] [Related]
4. Up-regulation of RAN by MYBL2 maintains osteosarcoma cancer stem-like cells population during heterogeneous tumor generation.
Gao W; Zhou J; Huang J; Zhang Z; Chen W; Zhang R; Kang T; Liao D; Zhong L
Cancer Lett; 2024 Apr; 586():216708. PubMed ID: 38336287
[TBL] [Abstract] [Full Text] [Related]
5. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic characteristics of a six-gene signature based on ssGSEA in sarcoma.
Liu J; Lu J; Wang G; Gu L; Li W
Aging (Albany NY); 2024 Jan; 16(2):1536-1554. PubMed ID: 38240704
[TBL] [Abstract] [Full Text] [Related]
7. m
Zhang D; Guo Q; You K; Zhang Y; Zheng Y; Wei T
J Orthop Surg Res; 2024 Jan; 19(1):33. PubMed ID: 38178201
[TBL] [Abstract] [Full Text] [Related]
8. Identification and experimental validation of Stearoyl-CoA desaturase is a new drug therapeutic target for osteosarcoma.
Nie J; He C; Shu Z; Liu N; Zhong Y; Long X; Liu J; Yang F; Liu Z; Huang P
Eur J Pharmacol; 2024 Jan; 963():176249. PubMed ID: 38070637
[TBL] [Abstract] [Full Text] [Related]
9. ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells.
Li S; Xue J; Zhang H; Shang G
J Orthop Surg Res; 2023 Nov; 18(1):910. PubMed ID: 38031136
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the role of lactylation-related genes in osteosarcoma: A deep dive into prognostic significance and therapeutic potential.
Sun J; Li Y; Chen R; Xie Y; Wei J; Li B
Environ Toxicol; 2024 Feb; 39(2):1001-1017. PubMed ID: 38009602
[TBL] [Abstract] [Full Text] [Related]
11. Genomic and Molecular Characteristics of Ovarian Carcinosarcoma.
Ramphal K; Hadfield MJ; Bandera CM; Hart J; Dizon DS
Am J Clin Oncol; 2023 Dec; 46(12):572-576. PubMed ID: 37986208
[TBL] [Abstract] [Full Text] [Related]
12. Molecular characterization of ferroptosis in soft tissue sarcoma constructs a prognostic and immunotherapeutic signature through experimental and bioinformatics analyses.
Yang ZQ; Guo LY; Xiao KW; Zhang C; Wu MH; Yan FF; Cai L
Aging (Albany NY); 2023 Oct; 15(20):11412-11447. PubMed ID: 37874682
[TBL] [Abstract] [Full Text] [Related]
13. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
14. Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma.
Guo W; Wang X; Lu B; Yu J; Xu M; Huang R; Cheng M; Yang M; Zhao W; Zou C
Cell Death Dis; 2023 Jul; 14(7):439. PubMed ID: 37460542
[TBL] [Abstract] [Full Text] [Related]
15. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B
Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689
[TBL] [Abstract] [Full Text] [Related]
16. myc regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma.
Nirala BK; Patel TD; Kurenbekova L; Shuck R; Dasgupta A; Rainusso N; Coarfa C; Yustein JT
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37279073
[TBL] [Abstract] [Full Text] [Related]
17. Histological and immunohistochemical prognostic factors of primary angiosarcoma.
Ichiki T; Yamada Y; Ito T; Nakahara T; Nakashima Y; Nakamura M; Yoshizumi T; Shiose A; Akashi K; Oda Y
Virchows Arch; 2023 Jul; 483(1):59-69. PubMed ID: 37261506
[TBL] [Abstract] [Full Text] [Related]
18. The Functional Role and Regulatory Mechanism of FTO m
Yang Q; Al-Hendy A
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175660
[TBL] [Abstract] [Full Text] [Related]
19. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling.
Giner F; Machado I; Rubio-Martínez LA; López-Guerrero JA; Claramunt-Alonso R; Navarro S; Ferrández A; Mayordomo-Aranda E; Llombart-Bosch A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108696
[TBL] [Abstract] [Full Text] [Related]
20. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract] [Full Text] [Related]
[Next]
